Latest Ask the Experts

Focal Therapy for Prostate Cancer: An Update

What are the major challenges regarding focal therapy for prostate cancer?

The New mCRPC Drugs

What have you learned about the differences in tolerability of the newer agents, adverse event profiles, and cost?

Latest Prostate Cancer News

Combined Urinary Testing Helps Detect Aggressive PCa, Avoid Biopsy

Combined Urinary Testing Helps Detect Aggressive PCa, Avoid Biopsy

Combining testing of urinary T2:ERG, PCA3 at thresholds that detected aggressive prostate cancer improved specificity from 18% to 39%.

Detection Down for Prostate Cancer, Up for Other Cancers Since ACA

Detection Down for Prostate Cancer, Up for Other Cancers Since ACA

The investigators found that the percentage of patients diagnosed with stage I cancer increased significantly from 2013 to 2014 after the ACA was implemented.

Prostate Cancer Subtypes Differ in ADT Response After Surgery

Prostate Cancer Subtypes Differ in ADT Response After Surgery

Only luminal B prostate cancers were significantly associated with postoperative response to ADT in a subset analysis in retrospective cohorts.

PCa Active Surveillance Safe, Effective for Younger Patients

PCa Active Surveillance Safe, Effective for Younger Patients

A majority of active surveillance patients under age 60 did not progress to definitive prostate cancer treatment.

MRI-Fusion Biopsy Benefits PCa Active Surveillance Patients

MRI-Fusion Biopsy Benefits PCa Active Surveillance Patients

Targeting PI-RADS 4 and 5 lesions for confirmatory biopsy improves detection of clinically significant cancer.

Sipuleucel-T Survival Benefit Greater in Blacks

Sipuleucel-T Survival Benefit Greater in Blacks

Median overall survival was 9.3 months longer for black versus white patients with metastatic castration-resistant prostate cancer.

Fusion Biopsy Ups Detection of Clinically Significant PCa

Fusion Biopsy Ups Detection of Clinically Significant PCa

Fusion biopsy has improved over the last decade and increasingly detects clinically significant prostate cancer, according to data trends from one institution.

Prostate Cancer Distant Metastasis Predicted by APV

Prostate Cancer Distant Metastasis Predicted by APV

Highest quartile of alkaline phosphatase velocity in men who experience biochemical recurrence after radical prostatectomy is associated with 2-fold higher risk.

Non-index Lesions at Biopsy Help Predict Adverse RP Outcomes

Non-index Lesions at Biopsy Help Predict Adverse RP Outcomes

Systematic biopsy parameters identified patients at higher risk of positive surgical margins.

HoLEP Feasible for BPH Patients With Low-risk Prostate Cancer

HoLEP Feasible for BPH Patients With Low-risk Prostate Cancer

The laser procedure was successful for 7 selected patients with enlarged prostates and LUTS harboring low-risk prostate cancer.

New Risk Models May Reduce Unnecessary Prostate Biopsies

New Risk Models May Reduce Unnecessary Prostate Biopsies

The new risk models improve upon PI-RADS version 1.0 and ERPSC risk calculators used for prostate biopsy decisions.

New Nomogram Improves Post-RP Metastasis Predictions

New Nomogram Improves Post-RP Metastasis Predictions

Nomogram based on a cohort of men with high-risk prostate cancer is more accurate than the CAPRA and MSKCC nomograms, researchers report.

Cholesterol Linked to High-Grade Prostate Cancer

Cholesterol Linked to High-Grade Prostate Cancer

Each 10 mg/dL increase in total cholesterol is associated with a significant 23% greater odds of high-grade prostate cancer.

Bone Metastasis at Diagnosis Predicts Early Prostate Cancer Mortality

Bone Metastasis at Diagnosis Predicts Early Prostate Cancer Mortality

Men who present with prostate cancer bone metastasis and no visceral metastases have a median survival time of 37 months, study finds.

Biopsy Timing in Active Surveillance Not Tied to PCa Reclassification

Biopsy Timing in Active Surveillance Not Tied to PCa Reclassification

But PSA density and body mass index are associated with prostate cancer reclassification.

Sign up for free e-Newsletters